INNOBIOSCIENCE LLC
BRADENTON, FLORIDA

InnoBioscience LLC is a clinical-stage biopharmaceutical company headquartered in Bradenton, Florida. Founded on July 17, 2013, the firm specializes in developing innovative therapies for autoimmune diseases, Multiple Sclerosis, Rheumatoid Arthritis, Alzheimer's Disease, Fibrosis, and Duchene Muscular Dystrophy. The company leverages a strategic collaboration with leading scientists to enhance research efficiencies within its focus areas. InnoBioscience is dedicated to accelerating research and discovering new treatments to address unmet medical needs through targeted inhalation delivery systems. InnoBioscience's strategy emphasizes close partnerships with top research scientists to optimize development processes, reduce costs, and secure government grants for product research. The company boasts a team of eminent scientists and clinical experts in the forefront of autoimmune diseases research. This experienced team has deep expertise in inhalation delivery mechanisms, positioning InnoBioscience uniquely to cultivate a robust portfolio for treating challenging medical conditions. The corporate structure classifies under FloridaModels.Dos.FloridaCompanyStatus with an official filing number, L13000101833. Its address is located at 707 24th Ave West, Bradenton, FL, and it maintains communication through several phone lines: (866) 363-3082; (941) 827-1136; and (866) 278-2874. InnoBioscience remains committed to its mission as underscored by its updated annual report from February 1, 2024. The company is led by Manager Annie Eng, who plays a critical role in overseeing corporate strategies and operations.